Bristol Myers Squibb highlights progress in treatment for cancer and blood disorders
First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm
First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm
Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time
With the approval from the Central Drugs Standard Control Organisation (CDSCO), Jardiance is now the first approved therapy to improve outcomes for the full spectrum of heart failure regardless of ejection fraction
This cost-effective tool will be of immense benefit to other high burden countries as well.
The latest certification endorses product for cold chain monitoring across 194 WHO member countries
The curriculum has been curated for General Physicians working in Clinikk
Union Minister of State for Science and Technology, Dr Jitendra Singh gave the award for the successful commercialization of indigenous technology on National Technology Day 2022
Wearable patch sensors (smart patches) are rising in popularity, as they offer a wide range of options for medical diagnosis
A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI
It is developing the drug candidate to potentially treat immunological diseases
Subscribe To Our Newsletter & Stay Updated